Glucocorticoid receptor
Assets acting on this target.
- Class
- Selective glucocorticoid receptor modulator
The glucocorticoid receptor (GR) is a nuclear hormone receptor that, once bound by cortisol or a synthetic corticosteroid, moves into the cell nucleus and regulates the transcription of many genes. Its natural role is to coordinate the body's response to stress and to restrain inflammation and immune activity. Because of this, GR agonists (corticosteroids) are among the most widely used anti-inflammatory and immunosuppressive medicines, applied topically for skin disease, inhaled for asthma and chronic obstructive pulmonary disease, and given systemically for a broad range of inflammatory and autoimmune conditions. The same receptor, however, also governs glucose metabolism, bone turnover, and fat distribution, so sustained activation can produce metabolic and structural side effects. This has motivated a complementary strategy: selective glucocorticoid receptor modulators and antagonists, which block or fine-tune GR signaling rather than activate it broadly. These agents are relevant in conditions of glucocorticoid excess, such as endogenous cortisol overproduction, or when clinicians wish to counteract corticosteroid-driven metabolic effects while preserving other treatment goals. Together, agonists and modulators illustrate how one receptor can be therapeutically exploited from opposite directions depending on the clinical need.
By indication
Related mechanisms
Glucocorticoid receptor drugs compared
23 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| albuterol / budesonideAirsupra | AstraZeneca | combination (SABA + ICS) | Approved | Approved in Asthma |
| Beclomethasone (QVAR) | Teva Pharmaceutical Industries | small molecule (corticosteroid) | Approved | Approved in Asthma |
| Betamethasone Dipropionate Emollient SpraySernivo | Encore Dermatology, Primus Pharmaceuticals | small molecule | Approved | Approved in Psoriasis |
| Budesonide (Entocort EC)Entocort EC | Padagis, Tillotts Pharma AG | small molecule | Approved | Approved in Crohn's Disease |
| budesonide (Ortikos)Ortikos | Sun Pharmaceutical Industries | Not recorded | Approved | Approved in Crohn's Disease |
| Budesonide (targeted-release)TARPEYO / Nefecon | Asahi Kasei Corporation, Calliditas Therapeutics, Everest Medicines (Beijing) Co., Ltd., STADA Arzneimittel | small molecule | Approved | Approved in IgA Nephropathy |
| Budesonide (Uceris rectal foam)Uceris rectal foam | Bausch Health | small molecule | Approved | Approved in Ulcerative Colitis |
| budesonide MMX (Uceris)Uceris | Bausch Health, Cosmo N.V., Ferring Pharmaceuticals | small molecule | Approved | Approved in Ulcerative Colitis |
| ciclesonide (Alvesco)Alvesco | Azurity Pharmaceuticals | small molecule (corticosteroid) | Approved | Approved in Asthma |
| Dexamethasone | Not recorded | small molecule | Approved | Approved in Crohn's Disease; Approved in Ulcerative Colitis |
| Dexamethasone (Dextenza)Dextenza | AffaMed Therapeutics, OCULAR THERAPEUTIX, INC | small molecule | Approved | Approved in Allergic Conjunctivitis; Approved in Ocular Inflammation and Pain |
| Fluticasone FuroateArnuity Ellipta | GlaxoSmithKline | small molecule (corticosteroid) | Approved | Approved in Asthma |
| fluticasone furoate/umeclidinium/vilanterolTrelegy Ellipta | GlaxoSmithKline | small molecule combination | Approved | Approved in Asthma; Approved in Chronic Obstructive Pulmonary Disease |
| fluticasone furoate/vilanterolBreo Ellipta | GlaxoSmithKline | small molecule combination | Approved | Approved in Asthma; Approved in Chronic Obstructive Pulmonary Disease |
| fluticasone propionate | GlaxoSmithKline | small molecule | Approved | Approved in Asthma |
| Fluticasone propionate/salmeterol (Advair HFA)Advair HFA | GlaxoSmithKline | combination (ICS + LABA) | Approved | Approved in Asthma |
| Halobetasol Propionate FoamLexette | Mayne Pharma | small molecule | Approved | Approved in Psoriasis |
| Halobetasol Propionate LotionBryhali | Bausch Health | small molecule | Approved | Approved in Psoriasis |
| hydrocortisone (Cortenema)Cortenema | ANI Pharmaceuticals, Inc. | small molecule | Approved | Approved in Ulcerative Colitis |
| hydrocortisone acetate (Cortifoam)Cortifoam | Viatris | small molecule | Approved | Approved in Ulcerative Colitis |
| Relacorilant (Lifyorli)Lifyorli | Corcept Therapeutics | small molecule | Approved | Approved in Ovarian Cancer; Phase 3 in Cushing's Syndrome |
| Dazucorilant | Corcept Therapeutics | small molecule | Phase 2 | Phase 2 in Amyotrophic Lateral Sclerosis |
| miricorilant | Corcept Therapeutics | small molecule | Phase 2 | Phase 2 in MASH / NASH |